Original articleStraightforward synthesis of pyrimido[4,5-e][1,4]diazepines via 6-aminopyrimidin-5-carbaldehydes
-
Add time:09/05/2019 Source:sciencedirect.com
A high-throughput method to obtain several pyrimido[4,5-e][1,4]diazepines is described by a two-step acylation/cyclization sequence from key intermediates 6-amino-5-(amino)methylpyrimidines, which were prepared from the precursor 6-aminopyrimidin-5-carbaldehydes. The acylation is accomplished with haloacyl halides to render ((4-aminopyrimidin-5-yl)-methyl)-2-haloamide intermediates. The cyclization step worked successfully, but depending on the substituents, competitive reactions versus the cyclization to pyrimido[4,5-e][1,4]diazepines were found to afford indolinones or acrylamides which were formed via alternative cyclization or elimination respectively. The pyrimido[4,5-e][1,4]diazepines were derivatized by alkylation at N(9), and a two-step one-pot procedure, cyclization/alkylation, from the ((pyrimidin-5-yl)-methyl)-2-haloamide intermediates was optimized to the formation of these N(9)-substituted derivatives.
We also recommend Trading Suppliers and Manufacturers of 5-(2-chloropropionyl) -2(1H,3H)-indolone (cas 138660-50-1). Pls Click Website Link as below: cas 138660-50-1 suppliers
Prev:Spectroscopic studies on the interactions of 5-ethyl-6-phenyl-3,8-bis((3-aminoalkyl)propanamido)phenanthridin-5-ium derivatives with G-quadruplex DNA
Next:ErratumDesign, synthesis and binding properties of novel and selective 5-HT3 and 5-HT4 receptor ligands☆☆☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Microwave-assisted synthesis of 1,5-dioxo-3-substituted [5]ferrocenophanes09/09/2019
- New [5]ferrocenophane diphosphine ligands for Pd-catalyzed allylic substitution09/08/2019
- Design, synthesis and binding properties of novel and selective 5-HT3 and 5-HT4 receptor ligands☆09/07/2019
- ErratumDesign, synthesis and binding properties of novel and selective 5-HT3 and 5-HT4 receptor ligands☆☆☆09/06/2019
- Spectroscopic studies on the interactions of 5-ethyl-6-phenyl-3,8-bis((3-aminoalkyl)propanamido)phenanthridin-5-ium derivatives with G-quadruplex DNA09/04/2019


